CLOV CLOVER HEALTH INVESTMENTS CO
FollowCOMMON STOCK (common), issuer CIK 1801170
218 managers (227 13F filers) reported a position in CLOV shares at 2026-06-30, 145,794,267 shares in all. 41 filers opened a position and 25 filers sold out during the quarter.
- Managers
- 218
- 13F filers
- 227
- New
- 41
- Added
- 76
- Reduced
- 56
- Sold out
- 25
- Shares held by filers
- 145,794,267
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Reynoso Jamie L.officer (CEO, Medicare Advantage) | 2026-10-07 | -2,006 S | $4.63 | Form 4 |
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
Reynoso Jamie L. sold 2,006 CLOV shares on 2026-10-07, Form 4 filed 2026-10-07. 0001839066-26-000054
Accepted , ingested